Standard BioTools (LAB) Margins & Profitability 2020-2026

Gross, EBITDA, operating, and net margin trends

Margins

Profit margins across the income statement

Gross Margin: 52.4%
EBITDA Margin: -120.0%
Op. Margin: -126.3%
Net Margin: -133.1%

Op. margin of -126.3% is down 8.2% YoY — costs are rising relative to revenue. Net margin at -133.1% and gross margin of 52.4% show how much of each revenue dollar survives to profit.

Gross Margin (%)

Revenue left after direct cost of goods sold

EBITDA Margin (%)

Operating profitability independent of capital structure

Operating & Net Margins (%)

How much of each dollar becomes profit